Enhanced External Counterpulsation on Delayed Onset Muscle Soreness
Not Applicable
Completed
- Conditions
- Muscle Tightness
- Interventions
- Device: Enhanced External Counterpulsation
- Registration Number
- NCT02175316
- Lead Sponsor
- David Grant U.S. Air Force Medical Center
- Brief Summary
This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
- Healthy active Duty or DoD beneficiaries between 25 and 59 years old
Exclusion Criteria
- Not on a physical profile
- Not taking any OTC or prescription pain medications or workout supplements
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Experimental: EECP for DOMS Enhanced External Counterpulsation All enrolled subjects will receive EECP treatment Delayed Onset Muscle Soreness.
- Primary Outcome Measures
Name Time Method Change in delayed onset muscle soreness over time. At 3, 6, 9, 12, 15, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48 Hours Likert pain surveys
- Secondary Outcome Measures
Name Time Method Bio-markers for muscle inflammation Baseline, 24 hours, 2 days 3 days 4 days 33 days Bio-markers for muscle inflammation: C-reactive protein, creatine phosphokinase, and white blood cell count.
Pain tolerance Baseline, 24 hours, 2 days 3 days 4 days 33 days Pain tolerance measured by mmHg pressure required to elicit a delayed-onset muscle pain response.
Trial Locations
- Locations (1)
David Grant USAF Medical Center
🇺🇸Travis Air Force Base, California, United States